# Safety of H1N1 Influenza Vaccination in Pregnant Women

> **NCT01842997** · PHASE4 · COMPLETED · sponsor: **Jiangsu Province Centers for Disease Control and Prevention** · enrollment: 122 (actual)

## Conditions studied

- Virus Diseases
- Respiratory Tract Infections
- Influenza
- Orthomyxoviridae Infections

## Interventions

- **BIOLOGICAL:** split-virion, non-adjuvanted H1N1 vaccine of 15 μg

## Key facts

- **NCT ID:** NCT01842997
- **Lead sponsor:** Jiangsu Province Centers for Disease Control and Prevention
- **Sponsor class:** NETWORK
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-10
- **Primary completion:** 2010-12
- **Final completion:** 2010-12
- **Target enrollment:** 122 (ACTUAL)
- **Last updated:** 2013-04-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01842997

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01842997, "Safety of H1N1 Influenza Vaccination in Pregnant Women". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01842997. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*